Access cutting-edge breast cancer treatment through this clinical trial at a research site in Springdale. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Springdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatment of HR-positive, HER2-negative advanced or metastatic breast cancer. HR-positive breast cancer cells have proteins on their surface called receptors that bind to hormones like estrogen and progesterone (female sex hormones). These hormones can promote the growth of cancer cells. HER2-negative describes cells that have a small amount or
Sponsor: Pfizer
Check if you qualify for this breast cancer clinical trial in Springdale, AR
If you're searching for breast cancer treatment options in Springdale, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.